Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer-Reference-Cited by-同舟云学术

Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer

Published:2022-09-09 Issue:1 Volume:29 Page:2959-2970
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Wathoni Nasrul¹²,Puluhulawa Lisa Efriani¹,Joni I Made²³,Muchtaridi Muchtaridi³⁴,Mohammed Ahmed Fouad Abdelwahab⁵⁶,Elamin Khaled M.⁷,Milanda Tiana⁸,Gozali Dolih¹

Affiliation:

1. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

2. Functional Nano Powder University Center of Excellence (FiNder U CoE), Universitas Padjadjaran, Sumedang, Indonesia

3. Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, Indonesia

4. Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

5. Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt

6. Graduate school of Pharmaceutical sciences, Kumamoto University, Kumamoto, Japan

7. Global Center for Natural Resources Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

8. Departement of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

Funder

Universitas Padjadjaran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2022.2120566

Reference106 articles.

1. Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells

2. Monoclonal antibody therapy of cancer

3. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review;Life Sciences;2024-09

3. Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications;Heliyon;2024-08

4. Theranostic nanoparticles for detection and treatment of pancreatic cancer;WIREs Nanomedicine and Nanobiotechnology;2024-07

5. Mass spectrometry imaging in pulmonary disorders;Clinica Chimica Acta;2024-07